1) Marine L. Pathological anatomy of exophtalmic goiter. Arch Intern Med 1911; 8: 265. 2) Marine L. Bening epithelial turnors of the thyroid gland. J Med Res 1913; 27: 229. 3) Biondeau P, Daou RG, René L. Nosologie des hiperthyroidies nodulares. Place du syndrome de Marine-Lenhart. Nouv Presse Méd 1976; 5: 411-4. 4) Blondeau P. Traiternent chirurgical de Ihperthyrdie. Introduction. Chirurgie 1978; 104(4). 707-8. 5) Charkes ND. Graves' disease with functioning nodules (Marine Lenhart syndrome). J Nucl Med 1972; 13(12): 885-92. 6) Konno N, Hirikawa J, Abe S. A case of Graves' disease associated with an autonomously functioning thyroíd nodule (AFTN) (Marine-Lenhart syndrorne) which spontaneously became a cold nodule. Endocr Jpn 1988; 35(5): 753-8. 7) Nisbikawa M, Yoshirnura M, Yoshikawa N, Toyoda N, Yonemoto T, Ogawa Y y col. Coexistence of an autonomously functioning thyroid nodule in a patient with Graves' disease: an unusual presentation of Marine-Lenhart syndrome. Endocr J 1997; 44(4): 571-4. 8) Carnell NE, Valente WA. Thyroid nodules in Graves' disease: classification, characterization and response to treatment (1). Thyroid 1998; 8: 571. 130 9) Daou RG, Daou, RG, Tabbara WS. A propós du syndrome de Marine-Lenhart. Présentation d'une observation anatomoclinique et scintigraphique. Chirurgie 1975; 101: 415. 10) Daou RG, Daou RG, Tabbara WS. A propós du syndrome de Marine-Lenhart. Présentation d'une observation anatomoclinique et scintigraphique. J Med Liban 1974; 27: 195. 11) Chandramouly B, Mann D, Cunningham RP, Giegerich E. Marine-Lenhart syndrome. Graves' discase with poorly functioníng nodules. Clin Nuel Med 1972; 17: 905. 12) Nmadu PT. Thyrotoxicosis in northern Nigeria: a rare disease. East Afr Med J 1989; 66: 585. 13) Carnell NE, Valente WA. Thyroid nodules in Graves' disease: classification, characterization and response to treatment (2). Thyroid 1998; 8: 647. 14) Kraimps JL, Bouin-Pineau MH, Maréchaud R, Barbierj. Nodules thyrdidiens associés: un argument de plus en faveur du traitement cffirurgical de la maladie de Basedow. Cffirurgie 1997; 122:488. 15) Sanchez J, Lamata F, Cerdan R, Aguilella V, Gastaminza R, Abusada R y col. Una Nueva Clasificación Ganimagráfico-Funcional de los Hipertiroidismos. An Fac Med 2000; 61(1): 15-20. 16) Werner SC. Classification of thyroid discase. Report of the committee on nomenclature the american thyroid association -Part 1. J Clin Endoc: Metab 1969; 29: 860. 17) Reinwein D, Benker G, $onig Mp, Pinchera A, Schatz H, Schleusener A. The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients. J Endoc Invest 1988; 11: 193. 18) Ozaki 0, Ito K, Manabe Y, Mimura T. Adenomatous goiter with hyperthyrodism. Jpn J Surg 1988; 18: 146. 19) Vergely N, Rachidi-koussa H, Clavier A, Caillot A, Decousus M, Estour B. Succession d'un adénome toxique et d'une maladie de Basedow. Presse Méd. 1995; 24: 371. 20) Puppel ID, Lebiond CP, Curtis GM. The surgical therapeutic significance of the functional behavior (radioiodine) of the thyroid nodules. Ann Surg 1947; 125: 257. 2 1) Lamberg BA, Gordin A, Viherkoski M, KYist G. Long acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' discase. Acta Endoc 1969; 62: 199. 22) Nygaard B, Kruidsen JH, Hegedüs L, Cand AV, Molholm JE. Thyrotropin receptor antibodies and Graves' discase, a side-effect of 114 treatment in patients with nontoxic goiter. J Clin Endoc Metab 1997; 82: 2926. 23) Grubeck-Loebenstein B, Derfier K, Kassal H, Knapp W, Krisch K, Liszka K et al. Inmunological features of nonimmunogenic hyperthyrodism. J Clin Endoc Metab 1985; 60: 150. 24) K¡y Y, Rezkallah-Iwasso MT, Perajofi MTS, Mota NGS. Inmunological disturbances in toxic multinodular goitre and active Graves' disease. Clin Endocr 198 1; 16: 11. 25) Poerti S, Kirner J, Salier B, Mann K, Hoerrnann R. T3-release from autonomously functioning thyroid nodules in vitro. Exp Clin Endocrino] Diabetes 1998; 106: 489. 26) Nygaard B, Faber J, Veje A, Hegedüs L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidisin triggered by '111 therapy. Thyroid 1999; 9: 477-81. 27) Orsolon P, Lupi A, De Antoni Migilorati G, Vianello Dr! A. Appareance of Graves' - flke disease following regression of autonomously functioning thyroid nodules. Two case reports. Minerva Endocrinol 1998; 23: 53. 28) Kasuga Y, Kobayashi S, Fuffirnori M, Shingu K, Hama Y, Ito K, Amano J. Development of Graves disease after surgical treatment for thyroid nodules: report of four cases. Endocr J 1997; 44: 567. 29) Wahl Ra, Rimpl I, Saalabian S, Schbram J. Differentiated operative therapy of autonomy (Plummer's disease). Exp Clin Endocrinol Diabetes 1998; 106(Suppl 4): 78. 30) Sanchez J, Lamata F, Cerdan R, Aguilella V, Gastaminza R, Abusada R y col. La Tiroidectomía Total en el Manejo Quirúrgico del Hipertiroidismo. Indicaciones, Resultados y Complicaciones. An Fac Med 1999; 60(3): 178-85.
|
